Kamdar; Chavda; Parikh, Journal of the Indian Chemical Society, 1987, vol. 64, # 5, p. 298 - 301
作者:Kamdar、Chavda、Parikh
DOI:——
日期:——
Gray; Buttle; Stephenson, Biochemical Journal, 1937, vol. 31, p. 724,727
作者:Gray、Buttle、Stephenson
DOI:——
日期:——
Selective COX-2 inhibitors. Part 2: Synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides
作者:Shwu-Jiuan Lin、Wei-Jern Tsai、Wen-Fei Chiou、Tsang-Hsiung Yang、Li-Ming Yang
DOI:10.1016/j.bmc.2007.11.033
日期:2008.3
Two series of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamide derivatives were designed and synthesized for the evaluation as selective cyclooxygenase-2 (COX-2) inhibitors in a cellular assay using human whole blood (HWB). Extensive structure-activity relationships (SAR) were studied within these series. Several compounds were found to be novel and selective COX-2 inhibitors. Among them, the most potent and selective was 4-(3-carboxy-4-hydroxy-benzylideneamino)benzenesulfonamide (20, LA2135), (IC50'S for COX- 1: 85.13 mu M; COX-2: 0.74 mu M; SI: 114.5), being more active COX-2 selective than celecoxib. (C) 2007 Elsevier Ltd. All rights reserved.
Carbonic anhydrase inhibitors. Part 35. Synthesis of Schiff bases derived from sulfanilamide and aromatic aldehydes: the first inhibitors with equally high affinity towards cytosolic and membrane-bound isozymes
作者:CT Supuran、A Nicolae、A Popescu
DOI:10.1016/0223-5234(96)85163-4
日期:1996.1
A series of Schiff bases was prepared by reaction of sulfanilamide with substituted benzene- and heterocyclic aldehydes. The compounds were characterized by standard procedures, and were assayed as inhibitors of the zinc enzyme carbonic anhydrase (CA). The new compounds act as inhibitors towards isozymes CA I and II (cytosolic) and CA IV (membrane-bound), and possess an equally high affinity for the last two, in contrast to classical inhibitors which are 17-33 times less effective against CA IV. This is the first evidence of high-affinity CA IV inhibitors, and might lead to the development of low molecular weight CA IV isozyme-specific derivatives.
1,2-Diphenylpyrrole derivatives, their preparation and their therapeutic uses